loadpatents
name:-0.0066978931427002
name:-0.0097789764404297
name:-0.00042200088500977
Rinker; James M. Patent Filings

Rinker; James M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rinker; James M..The latest application filed is for "substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes".

Company Profile
0.7.4
  • Rinker; James M. - Reading PA
  • Rinker, James M. - Schwenksville PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes
Grant 7,078,406 - Carver, Jr. , et al. July 18, 2
2006-07-18
4-pyridazinecarboxamides and esters as interleukin-1.beta. converting enzyme inhibitors
Grant 6,995,261 - Dolle , et al. February 7, 2
2006-02-07
Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes
App 20040248851 - Carver, Theodore E. JR. ;   et al.
2004-12-09
Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes
Grant 6,815,445 - Carver, Jr. , et al. November 9, 2
2004-11-09
Pyridazines as interleukin-1beta converting enzyme inhibitors
App 20040110725 - Dolle, Roland E. ;   et al.
2004-06-10
Peptide analogs as irreversible interleukin-1beta protease inhibitors
App 20040009923 - Dolle, Roland E. ;   et al.
2004-01-15
Pyridazines as interleukin-1.beta. converting enzyme inhibitors
Grant 6,624,166 - Dolle , et al. September 23, 2
2003-09-23
Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes
App 20030105111 - Carver, Theodore E. JR. ;   et al.
2003-06-05
Pyridazines as interleukin-1.beta. converting enzyme inhibitors
Grant 6,121,266 - Dolle , et al. September 19, 2
2000-09-19
Halomethyl amides as IL-1.beta. protease inhibitors
Grant 5,834,514 - Dolle , et al. November 10, 1
1998-11-10
Hydrogenated rapamycin derivatives
Grant 5,023,262 - Caufield , et al. June 11, 1
1991-06-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed